[HTML][HTML] Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants

S Bhagchandani, JA Johnson, DJ Irvine - Advanced drug delivery reviews, 2021 - Elsevier
Imidazoquinoline derivatives (IMDs) and related compounds function as synthetic agonists
of Toll-like receptors 7 and 8 (TLR7/8) and one is FDA approved for topical antiviral and skin …

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer

LAJ O'Neill, CE Bryant, SL Doyle - Pharmacological reviews, 2009 - ASPET
Since first being described in the fruit fly Drosophila melanogaster, Toll-like receptors (TLRs)
have proven to be of great interest to immunologists and investigators interested in the …

Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series

N Bou Karroum, G Moarbess, JF Guichou… - Journal of Medicinal …, 2019 - ACS Publications
The Toll-like receptors (TLRs) 7 and 8 play an important role in the immune system
activation, and their agonists may therefore serve as promising candidate vaccine adjuvants …

TLR2 agonistic small molecules: detailed structure–activity relationship, applications, and future prospects

A Kaur, D Kaushik, S Piplani, SK Mehta… - Journal of Medicinal …, 2020 - ACS Publications
Toll-like receptors (TLRs) are the pattern recognition receptors (PRRs) that recognize
pathogen-associated molecular patterns (PAMPs) in microbial species. Among the various …

[HTML][HTML] Toll-like receptor 4: a potential therapeutic target for multiple human diseases

J Wei, Y Zhang, H Li, F Wang, S Yao - Biomedicine & Pharmacotherapy, 2023 - Elsevier
The immune response plays a pivotal role in the pathogenesis of diseases. Toll-like receptor
4 (TLR4), as an intrinsic immune receptor, exhibits widespread in vivo expression and its …

Natural products with toll‐like receptor 4 antagonist activity

M Molteni, A Bosi, C Rossetti - International journal of …, 2018 - Wiley Online Library
Toll‐Like Receptors (TLRs) are the innate immunity receptors that play an activating role
when interacting with molecules released by bacteria and viruses (PAMPs, pathogen …

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists

K Cheng, M Gao, JI Godfroy, PN Brown… - Science …, 2015 - science.org
Toll-like receptor (TLR) agonists activate both the innate and the adaptive immune systems.
These TLR agonists have been exploited as potent vaccine adjuvants and antitumor agents …

Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9

D Wang, L Bhagat, D Yu, FG Zhu, JX Tang… - Journal of medicinal …, 2009 - ACS Publications
Oligodeoxyribonucleotides containing unmethylated CpG motifs act as TLR9 agonists. In
this study, we evaluated oligonucleotides containing an unmethylated CpG motif in which …

A chemical switch for transforming a purine agonist for toll-like receptor 7 to a clinically relevant antagonist

A Mukherjee, D Raychaudhuri, BP Sinha… - Journal of Medicinal …, 2020 - ACS Publications
Toll-like receptor 7 (TLR7) is an established therapeutic target in myriad autoimmune
disorders, but no TLR7 antagonist is available for clinical use to date. Herein, we report a …

[HTML][HTML] The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation

G Panter, R Jerala - Journal of Biological Chemistry, 2011 - ASBMB
Toll-like receptor 4 (TLR4) is involved in activation of the innate immune response in a large
number of different diseases. Despite numerous studies, the role of separate domains of …